GLP-1 RAs offer improved glycaemia, weight loss and cardiovascular benefits in those for whom they are recommended by the guidelines, so it is important that we facilitate their initiation and continuation in as many appropriate people as possible
There is no universal schedule for every patient
Impact on Liver Health Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity of obesity and type 2 diabetes
Geldmacher DS, Fritsch T, McClendon MJ, Landreth G
A post hoc subgroup analysis assessing changes in BMI standard-deviation scores between participants with one or more gastrointestinal adverse events and those with none revealed that the effect of liraglutide in reducing BMI standard-deviation scores was independent of gastrointestinal adverse events (P = 0.82) (245)
You can connect with a licensed doctor to discuss your eligibility for medications like Wegovy and Zepbound, all from the privacy and convenience of your home